cetylpyridinium chloride anhydrous has been researched along with Kahler Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaughnessy, JD | 1 |
| Alder, H; Aqeilan, RI; Boccadoro, M; Croce, CM; Drandi, D; Garzon, R; Hagan, JP; Kuehl, M; Ladetto, M; Munker, R; Palumbo, A; Palumbo, T; Pichiorri, F; Suh, SS; Taccioli, C; Volinia, S; Zanesi, N | 1 |
| Erickson, LD; Gleeson, MW; Noelle, RJ; O'Connor, BP | 1 |
| Burmester, GR; Egerer, K; Feist, E; Fleissner, C; Heider, U; Jakob, C; Kaiser, M; Kleeberg, L; Kloetzel, PM; Kuckelkorn, U; Liebisch, P; Sezer, O; Sterz, J; Türkmen, S; Zavrski, I | 1 |
| Barlogie, B; Chen, LC; Crowley, J; Dhodapkar, MV; Durie, B; Gure, AO; Jagannath, S; Kukreja, A; Matthews, P; Mazumder, A; Ritter, G; Scanlan, MJ; Shaughnessy, JD; Simpson, AJ; Spisek, R; Vesole, D; Zebroski, HA | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Kahler Disease
| Article | Year |
|---|---|
The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.
Topics: Animals; Antibody Formation; Cell Differentiation; Disease; Health; Humans; Multiple Myeloma; Plasma Cells | 2003 |
4 other study(ies) available for cetylpyridinium chloride anhydrous and Kahler Disease
| Article | Year |
|---|---|
Cancer: An unexpected addiction.
Topics: Animals; B-Lymphocytes; Cell Survival; Cell Transformation, Neoplastic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, myc; Health; Humans; Interferon Regulatory Factors; Multiple Myeloma; Proto-Oncogene Proteins c-myc | 2008 |
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Topics: Animals; Apoptosis Regulatory Proteins; Base Sequence; Bcl-2-Like Protein 11; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Health; Humans; Membrane Proteins; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; p300-CBP Transcription Factors; Plasma Cells; Proto-Oncogene Proteins; Receptors, Interleukin-6; Repressor Proteins; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Tumor Suppressor Protein p53; Up-Regulation | 2008 |
Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma.
Topics: Female; Health; Humans; Male; Multiple Myeloma; Prognosis; Proteasome Endopeptidase Complex; Protein Transport; Survival Rate | 2007 |
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.
Topics: Biomarkers; Cell Proliferation; Cells, Cultured; Disease Progression; Embryonic Stem Cells; Health; HMGB Proteins; Humans; Immunoglobulin G; Multiple Myeloma; Neoplasms; Paraproteinemias; SOXB1 Transcription Factors; T-Lymphocytes; Transcription Factors; Treatment Outcome | 2007 |